Pathology News
If you ask anyone who has been involved with digital pathology for the past 5 years or more that has studied the market from their respective perches, "Is the digital pathology market worth $200 million or $2 billion?" their answer would...
Nearly every day there seems to be exciting news or developments in the field of immunotherapy and immuno-oncology. Not only can you read all about immunotherapy research in leading scientific journals1, but the mainstream media now reports...
Medicine of course over the years has become increasingly technical. Imaging in particular has replaced, in my opinion, much of the art of medicine and replaced it with science. With advanced imaging techniques old questions get replaced with...
GTCR Acquires XIFIN
Chicago, IL and San Diego, CA -- July 30, 2014 -- GTCR, a leading private equity firm, today announced that it has acquired XIFIN, Inc. ("XIFIN" or "the Company"). XIFIN, headquartered in San Diego, California, is a leading provider of...
New to Insight Pharma Reports is Digital Pathology Insights: Imaging Technologies, Expert Perspectives, Standardization, and Current Outlooks. This report delves into the rapidly evolving field of digital pathology, briefly reviewing the...
Guest author, Dr. Dan Cruser, a practicing pathologist in New York and colleague of mine from residency provides a counterpoint to the use of telepathology networks in cases of extreme disruption to societies (i.e. war) and the control of...
